140,000 Bottles of Cholesterol Medication Recalled: Check Affected Products

ago 4 hours
140,000 Bottles of Cholesterol Medication Recalled: Check Affected Products

An important recall has been announced involving atorvastatin calcium tablets, a medication commonly prescribed to manage cholesterol levels. This recall affects approximately 140,000 bottles of various formulations of atorvastatin, necessitating immediate consumer awareness.

Details of the Recall

The recall includes several counts and dosages of atorvastatin calcium tablets. The affected products were identified by their National Drug Code (NDC) numbers and include various expiry dates. Health professionals and consumers are urged to review their supplies closely.

Affected Products

  • Atorvastatin Calcium Tablets USP, 10 mg
    • 90-count bottle (NDC 67877-511-90)
    • 500-count bottle (NDC 67877-511-05)
    • 1000-count bottle (NDC 67877-511-10)
  • Atorvastatin Calcium Tablets USP, 20 mg
    • 90-count bottle (NDC 67877-512-90)
    • 500-count bottle (NDC 67877-512-05)
    • 1000-count bottle (NDC 67877-512-10)
  • Atorvastatin Calcium Tablets USP, 40 mg
    • 90-count bottle (NDC 67877-513-90)
    • 500-count bottle (NDC 67877-513-05)
    • 1000-count bottle (NDC 67877-513-10)
  • Atorvastatin Calcium Tablets USP, 80 mg
    • 90-count bottle (NDC 67877-514-90)
    • 500-count bottle (NDC 67877-514-05)

Lot Numbers and Expiration Dates

The recalled atorvastatin bottles have specific lot numbers and expiration dates. Key lots are detailed below:

Dosage Lot Number Expiration Date
10 mg (90-count) 25141249 Feb. 2027
10 mg (500-count) 24144938 Nov. 2026
20 mg (90-count) 25140150 Dec. 2026
80 mg (90-count) 25140249 Dec. 2026

Recommendations for Consumers

Consumers who have these products should check their bottles for the listed lot numbers and expiration dates. If you possess recalled atorvastatin calcium tablets, it is advisable to cease usage and return the products to the pharmacy. Ensure that your healthcare provider is informed about any concerns related to the medication.

This recall underscores the importance of monitoring pharmaceutical products for safety. Stay vigilant and prioritize your health by verifying the medications in your possession.